Legend Biotech Corp - ADR
LEGN
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.45B
Close$
Share Statistics
| Market cap | $3.45 Billion |
|---|---|
| Enterprise Value | $3.05 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.6 |
| Beta | 0.4 |
| Outstanding Shares | 187,000,112 |
Return
| Return on Equity | -7.48% |
|---|---|
| Return on Assets | -5.25% |
| Return on Invested Capital | -3.16% |
Valuation & Multiples
| P/E Ratio | -37.28 |
|---|---|
| PEG | 29.5 |
| Price to Sales | 3.09 |
| Price to Book Ratio | 3.09 |
| Enterprise Value to Revenue | 2.4 |
| Enterprise Value to EBIT | -71.72 |
| Enterprise Value to Net Income | -34 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 0.23 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$0.12
Average shareholder expectationRevenue Estimate
$355.96 M
Average shareholder expectationNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
$0.02
Average shareholder expectationRevenue Estimate
$361.43 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.7048▼ 1.73% |
|---|---|
| Total Calls | 539,900▼ 5.15% |
| Total Puts | 380,500▼ 7.42% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 55.11%▲ 3.45% |
|---|---|
| Total Invested | $2.98B▲ 72.43% |
| Investors Holding | 230▲ 21.00% |
ESG Score
No data